This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, C.-Y. Articles by Lin, J.-T. Search for Related Content PubMed PubMed Citation Articles by Wu, C.-Y. Articles by Lin, J.-T.

Plasma Matrix Metalloproteinase-9 Level Is Better than Serum Matrix Metalloproteinase-9 Level to Predict Gastric Cancer Evolution

Authors' Affiliations: ¹ Graduate Institute of Clinical Medicine, College of Medicine; ² Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital; ³ Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan; ⁴ Division of Gastroenterology and ⁵ Department of Dermatology, Taichung Veterans General Hospital; ⁶ College of Public Health, China Medical University; and ⁷ Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan

Requests for reprints: Jaw-Town Lin, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Section 1, Chung-Shan S. Road, Taipei, 10017, Taiwan. Phone: 886-2-23562246; Fax: 886-2-23947899; E-mail: jawtown{at}ha.mc.ntu.edu.tw.

Purpose: Matrix metalloproteinase-9 (MMP-9) in blood is a promising new tumor marker. The aims of the present study are to compare the usefulness of plasma and serum MMP-9 levels for predicting gastric cancer development, invasion, and survival.

Experimental Design: In this nested case-control study, 114 gastric cancer patients and 87 healthy controls were enrolled. MMP-9 levels and activities were quantitatively measured by ELISA assay and zymography. The results were compared with the occurrence, clinicopathologic features, and outcomes of gastric cancer patients. The follow-up time for all patients was at least 5 years.

Results: Serum MMP-9 levels were significantly higher than plasma MMP-9 levels. Both plasma and serum MMP-9 levels correlated significantly with active MMP-9 identified by zymography (P = 0.002 and P = 0.048, respectively). Plasma MMP-9 level was significantly elevated in gastric cancer patients when compared with control subjects (P < 0.001). Serum MMP-9 levels did not differ between the groups. Receiver-operator characteristics analysis showed the values of sensitivity (82.5%) and specificity (65.5%) at the maximum accuracy for plasma MMP-9 at 60 ng/mL (P < 0.001). Elevated plasma MMP-9 correlated significantly with lymph node metastasis [odds ratio (OR), 3.43; P = 0.019], lymphatic invasion (OR, 7.58; P = 0.009), and venous invasion (OR, 4.14; P = 0.033). Patients with elevated plasma MMP-9 levels had poorer survival rates than those with normal plasma MMP-9 levels (P = 0.038). Serum MMP-9 level did not correlate well with gastric cancer–invasive phenotypes or survival.

Conclusion: Our results suggest plasma MMP-9 level is a better marker than serum MMP-9 level for predicting gastric cancer development and progression.

This article has been cited by other articles:

				K. Jung Matrix metalloproteinases do not properly work as peripheral blood biomarkers without taking into account the preanalytical impact of blood sampling Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 944 - 944. [Full Text] [PDF]

				K. Jung Matrix Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinase-1 in Serum Do Not Reflect the Analytes Circulating in Blood Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): e15 - e16. [Full Text] [PDF]

				Y.-H. Yang, H. Deng, W.-M. Li, Q.-Y. Zhang, X.-T. Hu, B. Xiao, H.-H. Zhu, P.-L. Geng, and Y.-Y. Lu Identification of Matrix Metalloproteinase 11 as a Predictive Tumor Marker in Serum Based on Gene Expression Profiling Clin. Cancer Res., January 1, 2008; 14(1): 74 - 81. [Abstract] [Full Text] [PDF]

				S.-F. Yang, P.-H. Wang, L.-Y. Lin, J.-L. Ko, G.-D. Chen, J.-S. Yang, H.-S. Lee, and Y.-S. Hsieh A Significant Elevation of Plasma Level of Matrix Metalloproteinase 9 in Patients With High-Grade Intraepithelial Neoplasia and Early Squamous Cell Carcinoma of the Uterine Cervix Reproductive Sciences, October 1, 2007; 14(7): 710 - 718. [Abstract] [PDF]